AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
LOWER URINARY-TRACT SYMPTOMS - A COMPARISON OF MICTURITION SYMPTOMS IN PATIENTS SCHEDULED FOR TRANSURETHRAL PROSTATIC RESECTION AND OUTPATIENTS OF BOTH SEXES REFERRED FOR NON-UROLOGICAL COMPLAINTS
Authors: BERGDAHL S AUS G LODDING P NORLEN L HUGOSSON J
Citation: S. Bergdahl et al., LOWER URINARY-TRACT SYMPTOMS - A COMPARISON OF MICTURITION SYMPTOMS IN PATIENTS SCHEDULED FOR TRANSURETHRAL PROSTATIC RESECTION AND OUTPATIENTS OF BOTH SEXES REFERRED FOR NON-UROLOGICAL COMPLAINTS, Scandinavian journal of urology and nephrology, 32(1), 1998, pp. 20-25
HORMONAL TREATMENT BEFORE RADICAL PROSTATECTOMY - A 3-YEAR FOLLOW-UP
Authors: AUS G ABRAHAMSSON PA AHLGREN G HUGOSSON J LUNDBERG S SCHAIN M SCHELIN S PEDERSEN K
Citation: G. Aus et al., HORMONAL TREATMENT BEFORE RADICAL PROSTATECTOMY - A 3-YEAR FOLLOW-UP, The Journal of urology, 159(6), 1998, pp. 2013-2016
MORTALITY FROM PROSTATE-CANCER AFTER NON-CURATIVE TREATMENT - PAST, PRESENT, FUTURE
Authors: AUS G HUGOSSON J
Citation: G. Aus et J. Hugosson, MORTALITY FROM PROSTATE-CANCER AFTER NON-CURATIVE TREATMENT - PAST, PRESENT, FUTURE, The Journal of urology, 159(5), 1998, pp. 483-483
SCREENING DETECTED PROSTATE-CANCER (PC) IN MALES AGED 50-66 YEARS WITH PROSTATE-SPECIFIC ANTIGEN (PSA) WITHIN THE INTERVAL 3-4 NG ML/
Authors: LODDING P AUS G BERGDAHL S FROSING R PIHL CG HUGOSSON J LILJA H
Citation: P. Lodding et al., SCREENING DETECTED PROSTATE-CANCER (PC) IN MALES AGED 50-66 YEARS WITH PROSTATE-SPECIFIC ANTIGEN (PSA) WITHIN THE INTERVAL 3-4 NG ML/, The Journal of urology, 159(5), 1998, pp. 900-900
HISTOPATHOLOGICAL CHANGES AND DOWN-REGULATION OF TUMOR-CELL PROLIFERATION AFTER 3 MONTHS OF GNRH-TREATMENT IS LESS FREQUENT IN PROSTATE-CANCER WITH NEUROENDOCRINE DIFFERENTIATION
Authors: AHLGREN G PEDERSEN K AUS G HUGOSSON J LUNDBERG S ABRAHAMSSON PA
Citation: G. Ahlgren et al., HISTOPATHOLOGICAL CHANGES AND DOWN-REGULATION OF TUMOR-CELL PROLIFERATION AFTER 3 MONTHS OF GNRH-TREATMENT IS LESS FREQUENT IN PROSTATE-CANCER WITH NEUROENDOCRINE DIFFERENTIATION, The Journal of urology, 159(5), 1998, pp. 1145-1145
CHARACTERISTICS OF SCREENING DETECTED PROSTATE-CANCER IN MEN 50 TO 66YEARS OLD WITH 3 TO 4 NG. ML. PROSTATE-SPECIFIC ANTIGEN/
Authors: LODDING P AUS G BERGDAHL S FROSING R LILJA H PIHL CG HUGOSSON J
Citation: P. Lodding et al., CHARACTERISTICS OF SCREENING DETECTED PROSTATE-CANCER IN MEN 50 TO 66YEARS OLD WITH 3 TO 4 NG. ML. PROSTATE-SPECIFIC ANTIGEN/, The Journal of urology, 159(3), 1998, pp. 899-903
NATURAL COURSE OF LOCALIZED PROSTATE-CANCER - A PERSONAL VIEW WITH A REVIEW OF PUBLISHED PAPERS
Authors: HUGOSSON J AUS G
Citation: J. Hugosson et G. Aus, NATURAL COURSE OF LOCALIZED PROSTATE-CANCER - A PERSONAL VIEW WITH A REVIEW OF PUBLISHED PAPERS, Anticancer research, 17(3A), 1997, pp. 1441-1448
15-YEAR SURVIVAL WITH PROSTATE-CANCER IN SWEDEN
Authors: AUS G HUGOSSON J
Citation: G. Aus et J. Hugosson, 15-YEAR SURVIVAL WITH PROSTATE-CANCER IN SWEDEN, JAMA, the journal of the American Medical Association, 278(3), 1997, pp. 205-206
STONE FORMATION IN THE PROSTATIC URETHRA AFTER CRYOTHERAPY FOR PROSTATE-CANCER
Authors: AUS G BERGDAHL S HUGOSSON J LUNDIN SE
Citation: G. Aus et al., STONE FORMATION IN THE PROSTATIC URETHRA AFTER CRYOTHERAPY FOR PROSTATE-CANCER, Urology, 50(4), 1997, pp. 615-617
DIAGNOSIS OF PROSTATE-CANCER - OPTIMAL NUMBER OF PROSTATE BIOPSIES RELATED TO SERUM PROSTATE-SPECIFIC ANTIGEN AND FINDINGS ON DIGITAL RECTAL EXAMINATION
Authors: AUS G AHLGREN G HUGOSSON J PEDERSEN KV RENSFELDT K SODERBERG R
Citation: G. Aus et al., DIAGNOSIS OF PROSTATE-CANCER - OPTIMAL NUMBER OF PROSTATE BIOPSIES RELATED TO SERUM PROSTATE-SPECIFIC ANTIGEN AND FINDINGS ON DIGITAL RECTAL EXAMINATION, Scandinavian journal of urology and nephrology, 31(6), 1997, pp. 541-544
NATURAL EVOLUTION OF PROSTATE-CANCER
Authors: HUGOSSON J AUS G
Citation: J. Hugosson et G. Aus, NATURAL EVOLUTION OF PROSTATE-CANCER, Endocrine-related cancer, 3(3), 1996, pp. 147-155
NONCURATIVE TREATMENT IN PROSTATE-CANCER - OUTCOME IN GOTEBORG
Authors: AUS G HUGOSSON J
Citation: G. Aus et J. Hugosson, NONCURATIVE TREATMENT IN PROSTATE-CANCER - OUTCOME IN GOTEBORG, Der Urologe, 35(6), 1996, pp. 449-453
THE RISK OF MALIGNANCY IN THE SURGICAL MARGIN AT RADICAL PROSTATECTOMY REDUCED ALMOST 3-FOLD IN PATIENTS GIVEN NEOADJUVANT HORMONE-TREATMENT
Authors: HUGOSSON J ABRAHAMSSON PA AHLGREN G AUS G LUNDBERG S SCHELIN S SCHAIN M PEDERSEN K
Citation: J. Hugosson et al., THE RISK OF MALIGNANCY IN THE SURGICAL MARGIN AT RADICAL PROSTATECTOMY REDUCED ALMOST 3-FOLD IN PATIENTS GIVEN NEOADJUVANT HORMONE-TREATMENT, European urology, 29(4), 1996, pp. 413-419
SURVEILLANCE IS NOT A VIABLE AND APPROPRIATE TREATMENT OPTION IN THE MANAGEMENT OF LOCALIZED PROSTATE-CANCER
Authors: HUGOSSON J AUS G NORLEN L
Citation: J. Hugosson et al., SURVEILLANCE IS NOT A VIABLE AND APPROPRIATE TREATMENT OPTION IN THE MANAGEMENT OF LOCALIZED PROSTATE-CANCER, Urologic clinics of North America, 23(4), 1996, pp. 557
REFERENCE RANGE OF PROSTATE-SPECIFIC ANTIGEN AFTER TRANSURETHRAL RESECTION OF THE PROSTATE
Authors: AUS G BERGDAHL S FROSING R LODDING P PILEBLAD E HUGOSSON J
Citation: G. Aus et al., REFERENCE RANGE OF PROSTATE-SPECIFIC ANTIGEN AFTER TRANSURETHRAL RESECTION OF THE PROSTATE, Urology, 47(4), 1996, pp. 529-531
PROSTATE-CANCER MORTALITY IN PATIENTS SURVIVING MORE THAN 10 YEARS AFTER DIAGNOSIS
Authors: HUGOSSON J AUS G BERGDAHL C BERGDAHL S GRONBERG H DAMBER JE DAMBER L JONSSON H
Citation: J. Hugosson et al., PROSTATE-CANCER MORTALITY IN PATIENTS SURVIVING MORE THAN 10 YEARS AFTER DIAGNOSIS, The Journal of urology, 156(5), 1996, pp. 1785-1786
EDITORIAL - WHAT TO EXPECT FROM PROSTATE-CANCER
Authors: HUGOSSON J AUS G
Citation: J. Hugosson et G. Aus, EDITORIAL - WHAT TO EXPECT FROM PROSTATE-CANCER, The Journal of urology, 156(3), 1996, pp. 1138-1138
LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT - REPLY
Authors: AUS G HUGOSSON J NORLEN L
Citation: G. Aus et al., LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT - REPLY, The Journal of urology, 155(6), 1996, pp. 2039-2041
LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT
Authors: AUS G HUGOSSON J NORLEN L ABRAHAMSSON PA ADAMI HO TAUBE A KIM KM ZELEN M KULLDORFF M
Citation: G. Aus et al., LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT, The Journal of urology, 155(1), 1996, pp. 296-297
CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY
Authors: ANDERSEN JT EKMAN P WOLF H BEISLAND HO JOHANSSON JE KONTTURI M LEHTONEN T TVETER K BODKER A VEDEL O NORDLING J POULSEN AL SCHOU J HVIDT V HANSEN JB MEYHOFF HH ELDRUP J HARTWELL D COLSTRUP H LYNGDORF P NIELSEN AH LARSEN E WALTER S LARSEN EH THYBO E MOMMSEN S BROK KE PALM L GENSTER H ANDERSEN M KAUPPINEN P RAUVALA M HAKKINEN J TAMMELA T TAINIO H HYNNINEN O TIITINEN J LEHTORANTA K ALAOPAS M PERTTILA I PETAS A RINTALA E SALMINEN R JUUSELA H HANSSON E VONWENDT R TUHKANEN K TALJA M NURMI M PUNTALA P PERMI J PUOLAKKA VM VIITANEN J GISLASON T EINARSSON GV ERI LM KARLSEN S HOLME P SIVERTSEN SM STEINSVIK E SERVOLL E URNES T MALME PA JOHANSEN TEB OMLAND H NAGELHUS J KLOSTER SE SKJEGGESTAD O VADA K MORTENSEN R NYBERG G PETTERSSON G WEDMAN L BRATELL S FOLMERZ P ZACKRISSON B DAHLGREN K TILLEGARD A AUS G BERGDAHL S HUGOSSON J HOLMQUIST B EK A RADEMARK C KRISTIANSEN P HERMANSSON CG PEDERSEN K OSCARSSON C KIHL B OLSSON JO NELVIN L LEISSNER KH LUNDSTAM S HJERTBERG H VARENHORST E ANDERSSON SO WINDAHL T SWARTZ R AHLBERG B GEDDA S ANDERSTROM C EDDELAND S HANSSON R STROGERG P ADOLFSSON J BAUER P KLEIST H STORM B RANCH T STRAVSNES H BREKKAN E EKLUND T KARLBERG L MALICE MP BRONEE V WENNERLUND P ERIKSSON LO AASERUD E LEHMUSSAARI J SUOMIN R GABRIEL MA
Citation: Jt. Andersen et al., CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY, Urology, 46(5), 1995, pp. 631-637
IMPACT OF COMPETING MORTALITY ON THE CANCER-RELATED MORTALITY IN LOCALIZED PROSTATE-CANCER
Authors: AUS G PILEBLAD E HUGOSSON J
Citation: G. Aus et al., IMPACT OF COMPETING MORTALITY ON THE CANCER-RELATED MORTALITY IN LOCALIZED PROSTATE-CANCER, Urology, 46(5), 1995, pp. 672-675
PROSTATE-CANCER MORTALITY IN PATIENTS SURVIVING MORE THAN 10 YEARS AFTER DIAGNOSIS
Authors: HUGOSSON J AUS G BERGDAHL C BERGDAHL S
Citation: J. Hugosson et al., PROSTATE-CANCER MORTALITY IN PATIENTS SURVIVING MORE THAN 10 YEARS AFTER DIAGNOSIS, The Journal of urology, 154(6), 1995, pp. 2115-2117
LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT
Authors: AUS G HUGOSSON J NORLEN L
Citation: G. Aus et al., LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT, The Journal of urology, 154(2), 1995, pp. 460-465
NEED FOR HOSPITAL-CARE AND PALLIATIVE TREATMENT FOR PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT
Authors: AUS G HUGOSSON J NORLEN L
Citation: G. Aus et al., NEED FOR HOSPITAL-CARE AND PALLIATIVE TREATMENT FOR PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT, The Journal of urology, 154(2), 1995, pp. 466-469
EFFECTS OF 3 MONTHS NEOADJUVANT HORMONAL TREATMENT WITH A GNRH ANALOG(TRIPTORELIN) PRIOR TO RADICAL RETROPUBIC PROSTATECTOMY ON PROSTATE-SPECIFIC ANTIGEN AND TUMOR VOLUME IN PROSTATE-CANCER
Authors: AUS G BRANDSTEDT S HAGGMAN M PEDERSEN K DELATORRE M HUGOSSON J
Citation: G. Aus et al., EFFECTS OF 3 MONTHS NEOADJUVANT HORMONAL TREATMENT WITH A GNRH ANALOG(TRIPTORELIN) PRIOR TO RADICAL RETROPUBIC PROSTATECTOMY ON PROSTATE-SPECIFIC ANTIGEN AND TUMOR VOLUME IN PROSTATE-CANCER, European urology, 26(1), 1994, pp. 22-28
Risultati: 1-25 | 26-30